Louis Maes
Louis Maes
Gewoon Hoogleraar, Universiteit Antwerpen
Verified email at
Cited by
Cited by
Progress on sanitation and drinking water–2015 update and MDG assessment
World Health Organization
World Health Organization, 2015
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
P Cos, AJ Vlietinck, DV Berghe, L Maes
Journal of ethnopharmacology 106 (3), 290-302, 2006
Quorum sensing inhibitors increase the susceptibility of bacterial biofilms to antibiotics in vitro and in vivo
G Brackman, P Cos, L Maes, HJ Nelis, T Coenye
Antimicrobial agents and chemotherapy 55 (6), 2655-2661, 2011
Leishmania–macrophage interactions: Insights into the redox biology
T Van Assche, M Deschacht, RAI da Luz, L Maes, P Cos
Free Radical Biology and Medicine 51 (2), 337-351, 2011
Open source drug discovery with the malaria box compound collection for neglected diseases and beyond
WC Van Voorhis, JH Adams, R Adelfio, V Ahyong, MH Akabas, P Alano, ...
PLoS pathogens 12 (7), e1005763, 2016
In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific …
M Vermeersch, RI da Luz, K Toté, JP Timmermans, P Cos, L Maes
Antimicrobial agents and chemotherapy 53 (9), 3855-3859, 2009
Advancing drug innovation for neglected diseases—criteria for lead progression
S Nwaka, B Ramirez, R Brun, L Maes, F Douglas, R Ridley
PLoS neglected tropical diseases 3 (8), e440, 2009
Inhibitory Effect of Biocides on the Viable Masses and Matrices of Staphylococcus aureus and Pseudomonas aeruginosa Biofilms
K Toté, T Horemans, DV Berghe, L Maes, P Cos
Applied and environmental microbiology 76 (10), 3135-3142, 2010
Biofilms: an extra hurdle for effective antimicrobial therapy
P Cos, K Tote, T Horemans, L Maes
Current pharmaceutical design 16 (20), 2279-2295, 2010
Extended structure–activity relationship and pharmacokinetic investigation of (4-quinolinoyl) glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP)
K Jansen, L Heirbaut, R Verkerk, JD Cheng, J Joossens, P Cos, L Maes, ...
Journal of medicinal chemistry 57 (7), 3053-3074, 2014
Plant substances as anti-HIV agents selected according to their putative mechanism of action
P Cos, L Maes, D Vanden Berghe, N Hermans, L Pieters, A Vlietinck
Journal of Natural Products 67 (2), 284-293, 2004
A prodrug form of a Plasmodium falciparum glutathione reductase inhibitor conjugated with a 4-anilinoquinoline
E Davioud-Charvet, S Delarue, C Biot, B Schwöbel, CC Boehme, ...
Journal of medicinal chemistry 44 (24), 4268-4276, 2001
Synthesis, cytotoxicity, and antiplasmodial and antitrypanosomal activity of new neocryptolepine derivatives
THM Jonckers, S Van Miert, K Cimanga, C Bailly, P Colson, ...
Journal of Medicinal Chemistry 45 (16), 3497-3508, 2002
PLGA nanoparticles and nanosuspensions with amphotericin B: potent in vitro and in vivo alternatives to Fungizone and AmBisome
H Van de Ven, C Paulussen, PB Feijens, A Matheeussen, P Rombaut, ...
Journal of controlled release 161 (3), 795-803, 2012
Antimalarial, antitrypanosomal, and antileishmanial activities and cytotoxicity of bis (9-amino-6-chloro-2-methoxyacridines): influence of the linker
S Girault, P Grellier, A Berecibar, L Maes, E Mouray, P Lemiere, ...
Journal of medicinal chemistry 43 (14), 2646-2654, 2000
Selective inhibitors of fibroblast activation protein (FAP) with a (4-quinolinoyl)-glycyl-2-cyanopyrrolidine scaffold
K Jansen, L Heirbaut, JD Cheng, J Joossens, O Ryabtsova, P Cos, ...
ACS medicinal chemistry letters 4 (5), 491-496, 2013
Synthesis and in Vitro and in Vivo Antimalarial Activity of N-(7-Chloro-4-quinolyl)-1, 4-bis (3-aminopropyl) piperazine Derivatives
A Ryckebusch, R Deprez-Poulain, L Maes, MA Debreu-Fontaine, ...
Journal of medicinal chemistry 46 (4), 542-557, 2003
Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent
H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ...
Elife 5, e12613, 2016
Plant-derived leading compounds for chemotherapy of human immunodefiency virus (HIV) infection–an update (1998–2007)
P Cos, L Maes, A Vlietinck, L Pieters
Planta Medica, 1323-1337, 2008
Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp
G Brackman, S Celen, U Hillaert, S Van Calenbergh, P Cos, L Maes, ...
PLoS One 6 (1), e16084, 2011
The system can't perform the operation now. Try again later.
Articles 1–20